Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy M Murray

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Targeting the purinomeJeremy M Murray, Dirksen E Bussiere
Drug Discovery Today. Technologies|June 16, 2019
Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanismsIngrid E Wertz, Jeremy M Murray
Current Topics in Medicinal Chemistry|July 18, 2006
Targeting cancer: the challenges and successes of structure-based drug design against the human purinomeMark Knapp, Cornelia Bellamacina, Jeremy M Murray, et al.
The Biochemical Journal|May 3, 2002
Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogueColin G Saysell, Winston S Tambyrajah, Jeremy M Murray, et al.
Nature Chemical Biology|November 27, 2012
Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7Yingnan Zhang, Lijuan Zhou, Lionel Rouge, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2006
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studiesXiaodong Lin, Jeremy M Murray, Alice C Rico, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2017
Structural insights into lipoprotein N-acylation by <i>Escherichia coli</i> apolipoprotein N-acyltransferaseCameron L Noland, Michele D Kattke, Jingyu Diao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Molecular basis for negative regulation of the glucagon receptorChristopher M Koth, Jeremy M Murray, Susmith Mukund, et al.
Journal of Medicinal Chemistry|November 23, 2017
Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico TechniquesPaola Di Lello, Richard Pastor, Jeremy M Murray, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral AnglesBrian S Safina, Richard L Elliott, Andrew K Forrest, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Targeting the purinomeJeremy M Murray, Dirksen E Bussiere
Drug Discovery Today. Technologies|June 16, 2019
Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanismsIngrid E Wertz, Jeremy M Murray
Current Topics in Medicinal Chemistry|July 18, 2006
Targeting cancer: the challenges and successes of structure-based drug design against the human purinomeMark Knapp, Cornelia Bellamacina, Jeremy M Murray, et al.
The Biochemical Journal|May 3, 2002
Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogueColin G Saysell, Winston S Tambyrajah, Jeremy M Murray, et al.
Nature Chemical Biology|November 27, 2012
Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7Yingnan Zhang, Lijuan Zhou, Lionel Rouge, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2006
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studiesXiaodong Lin, Jeremy M Murray, Alice C Rico, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2017
Structural insights into lipoprotein N-acylation by <i>Escherichia coli</i> apolipoprotein N-acyltransferaseCameron L Noland, Michele D Kattke, Jingyu Diao, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2012
Molecular basis for negative regulation of the glucagon receptorChristopher M Koth, Jeremy M Murray, Susmith Mukund, et al.
Journal of Medicinal Chemistry|November 23, 2017
Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico TechniquesPaola Di Lello, Richard Pastor, Jeremy M Murray, et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral AnglesBrian S Safina, Richard L Elliott, Andrew K Forrest, et al.
Pageof 3